Xconomy |
Dermira Commits $ 135M for Global Rights to Roche Eczema Drug
Xconomy Skin treatments developer Dermira is adding another experimental drug to its pipeline that it plans to test as a potential treatment for eczema, through a deal announced this morning with healthcare giant Roche. But in picking up the global rights to … |